Quantification of cancer risk in glomerulonephritis

[1]  C. Porta,et al.  Glomerular diseases and cancer: evaluation of underlying malignancy , 2015, Journal of Nephrology.

[2]  E. Knight,et al.  Prevalence of Cancer in Membranous Nephropathy: A Systematic Review and Meta-Analysis of Observational Studies , 2014, American Journal of Nephrology.

[3]  J. Radhakrishnan,et al.  Glomerular diseases seen with cancer and chemotherapy: a narrative review. , 2013, Kidney international.

[4]  P. Ronco,et al.  Onco-nephrology: glomerular diseases with cancer. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[5]  L. Lai,et al.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis , 2011, Nature Reviews Nephrology.

[6]  L. Beck.  Membranous nephropathy and malignancy. , 2010, Seminars in nephrology.

[7]  Jacques Ferlay,et al.  NORDCAN – a Nordic tool for cancer information, planning, quality control and research , 2010, Acta oncologica.

[8]  J. Bacchetta,et al.  Paraneoplastic glomerular diseases and malignancies. , 2009, Critical reviews in oncology/hematology.

[9]  Ralf Küppers,et al.  The biology of Hodgkin's lymphoma , 2009, Nature Reviews Cancer.

[10]  C. Zeng,et al.  Etiology and clinical characteristics of membranous nephropathy in Chinese patients. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Ivar Heuch,et al.  Association of albuminuria and cancer incidence. , 2008, Journal of the American Society of Nephrology : JASN.

[12]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[13]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[14]  F. Langmark,et al.  Long-term risk of cancer in membranous nephropathy patients. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  P. Pham,et al.  Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies , 2006, Clinical and Experimental Nephrology.

[16]  N. Brousse,et al.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. , 2006, Kidney international.

[17]  J. Grünfeld,et al.  Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  J. Heaf.  The Danish Renal Biopsy Register. , 2004, Kidney international.

[19]  H. Storm,et al.  Glomerulonephritis and malignancy: a population-based analysis. , 2003, Kidney international.

[20]  A. Polliack,et al.  Kidney involvement and renal manifestations in non‐Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients , 2001, European journal of haematology.

[21]  J. Nagy,et al.  Renal Cell Carcinoma and Paraneoplastic IgA Nephropathy , 1999, Nephron.

[22]  N. Marcussen,et al.  Reproducibility of the WHO classification of glomerulonephritis. , 1995, Clinical nephrology.

[23]  J. Mustonen,et al.  Proteinuria and haematuria are frequently present in patients with lung cancer. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  R. Gabriel,et al.  Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies , 1988, British medical journal.

[25]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.

[26]  J. Lee,et al.  The association of cancer and the nephrotic syndrome. , 1966, Annals of internal medicine.